Azurity Pharmaceuticals, Inc v. Novitium Pharma, LLC
Azurity Pharmaceuticals, Inc v. Novitium Pharma, LLC is a federal antitrust lawsuit filed on 02/29/2024 in the District Court, D. Delaware. The case was terminated on 03/25/2024.
- Court
- District Court, D. Delaware (D. Del.)
Official Court Website → - Assigned judge
- Mitchell S. Goldberg · 282 cases in index
- Docket number
- 1:24-mc-00102
- Cause
- 15:15 Antitrust Litigation
15 U.S.C. § 15 — Clayton Act (private antitrust suits) - Nature of suit
- 410 Anti-Trust
Claims of unlawful restraint of trade, monopolization, or anticompetitive conduct under the Sherman and Clayton Acts. - Jurisdiction
- Federal Question
- Jury demand
- None
- Date filed
- 02/29/2024
- Date terminated
- 03/25/2024
254 Antitrust cases in this court are indexed here.
Parties
- plaintiff · Azurity Pharmaceuticals, Inc · 26 cases
- defendant · Novitium Pharma LLC · 7 cases
Part of a Larger Litigation Pattern
This is one of 8 Antitrust cases in our index naming Novitium Pharma LLC — a possible mass-tort or coordinated-litigation cluster.
About Antitrust Lawsuits
Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.
Frequently Asked Questions
What is Azurity Pharmaceuticals, Inc v. Novitium Pharma, LLC?
Azurity Pharmaceuticals, Inc v. Novitium Pharma, LLC is a federal antitrust lawsuit filed on 02/29/2024 in the District Court, D. Delaware. The case was terminated on 03/25/2024. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.
What type of case is this?
It is classified as “Antitrust” under the federal nature-of-suit system. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.
What court is the case in?
The case is in the District Court, D. Delaware, docket number 1:24-mc-00102.
When was the case filed?
Azurity Pharmaceuticals, Inc v. Novitium Pharma, LLC was filed on 02/29/2024. It was terminated on 03/25/2024.
What law is the case brought under?
The docket lists the cause as 15 U.S.C. § 15 — Clayton Act (private antitrust suits).
Other Cases Involving These Parties
Related Antitrust Cases
Source: public U.S. federal court record (docket 68297387).